资本押注“中国智造”！柳叶刀医疗机器人获A+轮融资，破解卡脖子难题

Core Viewpoint - The article highlights the recent A+ round financing of "Liuyedao," a medical surgical robot developer, which raised several million yuan to enhance its product development and global commercialization efforts [1]. Company Overview - Liuyedao (Shenzhen Liuyedao Robot Co., Ltd.) specializes in providing comprehensive AI surgical robot solutions for medical institutions, with a product range covering key clinical areas such as joint replacement, spinal trauma, oral implantation, neurosurgery, and vascular intervention [1][3]. - The founding team, led by Huang Zhijun, has a strong background in engineering and clinical medicine, with members from prestigious institutions and experience in notable companies like Siemens Medical and Hikvision [3]. Product Development - Liuyedao focuses on the independent development of surgical robots for spinal/trauma, joint replacement, oral implantation, and vascular intervention, with key products including hip-knee integrated joint replacement robots and oral implantation navigation robots [3]. - The company has achieved 100% localization of core components and has filed nearly 400 intellectual property applications, including 166 invention patents, breaking the technical monopoly of imported surgical robots [3]. Market Demand and Growth Potential - The Dencore® oral implantation navigation robot, designed with real-time tracking and precise positioning capabilities, has received regulatory approval and is expected to capture significant market share in the growing oral health sector [5]. - The RobPath® hip joint replacement navigation system offers intelligent surgical planning and high-precision positioning, having received dual certification from both China's NMPA and the US FDA [7]. Current Usage and Future Plans - Liuyedao's surgical robots are already in use in various hospitals, including grassroots and private specialty hospitals, indicating a broadening customer base [8]. - The company plans to accelerate the registration and market launch of multiple domestic surgical robots, aiming to expand its global footprint in the medical robotics sector [8].